These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 24961320

  • 1. Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome.
    Köninger A, Koch L, Edimiris P, Enekwe A, Nagarajah J, Kasimir-Bauer S, Kimmig R, Strowitzki T, Schmidt B.
    Arch Gynecol Obstet; 2014 Nov; 290(5):1023-30. PubMed ID: 24961320
    [Abstract] [Full Text] [Related]

  • 2. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S, Atakul N, Aydogan B, Aydin Y, Imamoglu M, Seyisoglu H.
    Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
    [Abstract] [Full Text] [Related]

  • 3. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome.
    Pigny P, Jonard S, Robert Y, Dewailly D.
    J Clin Endocrinol Metab; 2006 Mar; 91(3):941-5. PubMed ID: 16368745
    [Abstract] [Full Text] [Related]

  • 4. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, Cohen A, Hougaard DM, Nyboe Andersen A.
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [Abstract] [Full Text] [Related]

  • 5. Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome.
    Le MT, Le VNS, Le DD, Nguyen VQH, Chen C, Cao NT.
    Clin Endocrinol (Oxf); 2019 Apr; 90(4):579-585. PubMed ID: 30636332
    [Abstract] [Full Text] [Related]

  • 6. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S, Laven JSE, Duhamel A, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1723-1731. PubMed ID: 28854584
    [Abstract] [Full Text] [Related]

  • 7. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T, Panichyawat N, Indhavivadhana S, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, Pratumvinit B, Sa-Nga-Areekul N.
    Taiwan J Obstet Gynecol; 2018 Aug 01; 57(4):499-506. PubMed ID: 30122568
    [Abstract] [Full Text] [Related]

  • 8. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 Aug 01; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 9. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.
    Sova H, Unkila-Kallio L, Tiitinen A, Hippeläinen M, Perheentupa A, Tinkanen H, Puukka K, Bloigu R, Piltonen T, Tapanainen JS, Morin-Papunen L.
    Gynecol Endocrinol; 2019 Jul 01; 35(7):595-600. PubMed ID: 30668196
    [Abstract] [Full Text] [Related]

  • 10. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
    Dewailly D, Pigny P, Soudan B, Catteau-Jonard S, Decanter C, Poncelet E, Duhamel A.
    J Clin Endocrinol Metab; 2010 Sep 01; 95(9):4399-405. PubMed ID: 20610596
    [Abstract] [Full Text] [Related]

  • 11. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
    Li Y, Wei LN, Xiong YL, Liang XY.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug 01; 45(8):567-70. PubMed ID: 21029609
    [Abstract] [Full Text] [Related]

  • 12. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.
    Yetim A, Yetim Ç, Baş F, Erol OB, Çığ G, Uçar A, Darendeliler F.
    J Clin Res Pediatr Endocrinol; 2016 Sep 01; 8(3):288-97. PubMed ID: 27125339
    [Abstract] [Full Text] [Related]

  • 13. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
    Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D.
    Am J Physiol Endocrinol Metab; 2009 Feb 01; 296(2):E238-43. PubMed ID: 18957615
    [Abstract] [Full Text] [Related]

  • 14. [CORRELATION OF ANTI-MULLERIAN HORMONE WITH HORMONAL AND OVARIAN MORPHOLOGICAL CHARACTERISTICS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME WITH AND WITHOUT INSULIN RESISTANCE].
    Asanidze E, Khristesashvili J, Pkhaladze L, Barbakadze L.
    Georgian Med News; 2018 Feb 01; (Issue):34-40. PubMed ID: 29578420
    [Abstract] [Full Text] [Related]

  • 15. [A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].
    Yang S, Ruan J, Huang W, Tan J, Zhang X, Feng X, Liu D, Fu J, Zhou L, Zhou M.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov 01; 50(11):819-24. PubMed ID: 26887768
    [Abstract] [Full Text] [Related]

  • 16. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F, Liu XL, Rong N, Huang XW.
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb 01; 37(1):70-73. PubMed ID: 28224431
    [Abstract] [Full Text] [Related]

  • 17. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
    Hum Reprod; 2005 Jul 01; 20(7):1820-6. PubMed ID: 15802325
    [Abstract] [Full Text] [Related]

  • 18. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D, Alebić MŠ, Duhamel A, Stojanović N.
    Hum Reprod; 2014 Nov 01; 29(11):2536-43. PubMed ID: 25267785
    [Abstract] [Full Text] [Related]

  • 19. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
    Łebkowska A, Adamska A, Karczewska-Kupczewska M, Nikołajuk A, Otziomek E, Milewski R, Górska M, Wołczyński S, Kowalska I.
    Metabolism; 2016 May 01; 65(5):804-811. PubMed ID: 26961579
    [Abstract] [Full Text] [Related]

  • 20. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
    Leonhardt H, Hellström M, Gull B, Lind AK, Nilsson L, Janson PO, Stener-Victorin E.
    Fertil Steril; 2014 Jun 01; 101(6):1747-56.e1-3. PubMed ID: 24661732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.